Doxorubicin Terminated Phase 2 Trials for Metastatic Breast Cancer (MBC) Treatment

IndicationsStatusPurposePhase
TerminatedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00574236Phase II Trial of Bortezomib and Doxorubicin in Metastatic Breast Cancer
NCT00691912Therapy of Metastatic Breast Cancer With Paclitaxel and Liposomal Doxorubicin